Amy Parker Ruhl, MD | |
600 N Wolfe St, Baltimore, MD 21287 | |
(410) 955-5000 | |
Not Available |
Full Name | Amy Parker Ruhl |
---|---|
Gender | Female |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 600 N Wolfe St, Baltimore, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023155876 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | D69053 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amy Parker Ruhl, MD 1020 Park Ave, Apt# 611, Baltimore, MD 21201-5640 Ph: (434) 466-7275 | Amy Parker Ruhl, MD 600 N Wolfe St, Baltimore, MD 21287 Ph: (410) 955-5000 |
News Archive
Schering AG, Germany announced today that, following regulatory approvals, it will co-promote the novel oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK) for all oncology indications together with Novartis Pharma AG in Europe, North America and Japan. This agreement will enable both Schering and Novartis to maximize the compound's full potential.
Researchers at Georgia State University's College of Education have been awarded a significant $10 million grant to create the first national research center aimed at dramatically improving reading for children who are deaf or hard of hearing (DHH).
According to a latest study, adults between ages 25 and 54 infected with HIV, are at increased risk for bone fractures compared to the general population. Until now it was known that low bone mineral density was common in people with HIV, but no concrete proof existed.
Researchers from the University of Massachusetts have found that pregnant women with gestational diabetes have a higher rate of passing on harmful synthetic chemicals called PFAS (17 - per- and polyfluoroalkyl substances) to their unborn babies and thus risking their health.
The largest study of patients with severe asthma to date, published in The Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50% reduction in severe exacerbations, emergency room visits, and hospitalisations compared with patients given placebo.
› Verified 6 days ago
Dr. Leonard Anang Sowah, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062 | |
Dr. Bhavandeep Singh Bajaj, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484 | |
Dr. Yonas Sisay, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672 | |
Dr. Stephen John Witanowski, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867 | |
Dr. Susrutha Kotwal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018 | |
Dr. Mitesh G Trambadia, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786 | |
Ronak K Patel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000 |